Trends in Chronic Pain and Its Management Among Nursing Home Residents With Dementia
A team of investigators evaluated numerous factors associated with the management of pain among residents of nursing homes with dementia.
Diagnosis & Disease Information
What the Buprenorphine X-Waiver Removal Means for Clinicians
AANP and AAPA Presidents discuss how elimination of the X-Waiver and patient caps for buprenorphine prescription for opioid use disorder will affect clinical practice.
HIV Serostatus Affects Hepatitis C Virus Care Cascade
Researchers sought to evaluate differences in immunologic markers between those with HIV and those at risk for HIV with opioid use disorder.
How to Improve Health Disparities in Acute Pain Management in Emergency Departments
Retrospective chart review shows health disparities in acute pain management among racial/ethnic minority patients and women in an emergency department.
Opioids Frequently Prescribed to Patients With Cirrhosis
Opiate prescriptions predicted by primary care physician specialty and patient age, gender, race.
Substance Use Disorders During the COVID-19 Pandemic: Case Study
A 45-year-old man presents to his primary care office at 9:00 AM after he was asked to leave work the day before because he smelled of alcohol and had been acting erratically.
Addiction Treatment Proponents Urge Rural Clinicians to Pitch in by Prescribing Medication
The number of US health care providers certified to prescribe buprenorphine more than doubled in the past 4 years, and treatment advocates hope to see that trend continue.
Narcan Nasal Spray Gets Priority Review for OTC Treatment of Opioid Overdose
If approved, the OTC nasal spray would deliver 4 mg of naloxone per spray.
CDC Releases Updated Guidance on Prescribing Opioid Pain Medication
The 2022 CDC Clinical Practice Guideline is intended to help clinicians weigh the benefits and risks of opioids and alternative pain treatments for outpatients.
Why Is Methadone So Hard to Prescribe for Opioid Use Disorder?
Jim Anderson, MPAS, PA-C, wonders if SAMHSA will make the methadone take-home flexibility program permanent.
- Loading...
Loading...
Next post in The Waiting Room
Loading... 
Loading...